|
|
|
Insider
Information: |
Stahl Neil |
Relationship: |
EVP Research and Devel... |
City: |
|
State: |
|
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
1 |
|
Direct
Shares |
50,999 |
|
Indirect Shares
|
10,439 |
|
|
Direct
Value |
$49,630,187 |
|
|
Indirect Value
|
$10,158,817 |
|
|
Total
Shares |
61,438 |
|
|
Total
Value |
$59,789,004 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
5
|
Stock
price went up :
|
0
|
4
|
Stock
price went down : |
0
|
1
|
|
|
|
Gain/Loss Ratio : |
0.0
|
4.0
|
Percentage
Gain/Loss : |
0.0%
|
57.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Regeneron Pharmaceuticals Inc |
REGN |
EVP Research and Devel... |
2024-02-26 |
50,999 |
2024-02-26 |
10,439 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
140 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 4 of 6
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
REGN |
Regeneron Pharmaceuticals... |
SVP Res & Dev Sciences |
|
2012-06-18 |
4 |
OE |
$20.32 |
$1,932,005 |
D/D |
95,079 |
154,200 |
0 |
- |
|
REGN |
Regeneron Pharmaceuticals... |
SVP Res & Dev Sciences |
|
2012-06-18 |
4 |
D |
$115.29 |
$6,475,609 |
D/D |
(56,168) |
98,032 |
0 |
- |
|
REGN |
Regeneron Pharmaceuticals... |
SVP Res & Dev Sciences |
|
2012-06-19 |
4 |
AS |
$115.60 |
$4,514,593 |
D/D |
(38,911) |
59,121 |
0 |
- |
|
REGN |
Regeneron Pharmaceuticals... |
SVP Res and Dev Sciences |
|
2009-07-24 |
4 |
AS |
$20.00 |
$210,740 |
D/D |
(10,537) |
350 |
0 |
- |
|
REGN |
Regeneron Pharmaceuticals... |
SVP Res and Dev Sciences |
|
2009-07-24 |
4 |
D |
$20.14 |
$1,260,301 |
D/D |
(62,577) |
27,236 |
0 |
- |
|
REGN |
Regeneron Pharmaceuticals... |
SVP Res and Dev Sciences |
|
2009-07-24 |
4 |
OE |
$9.49 |
$949,000 |
D/D |
100,000 |
89,813 |
0 |
- |
|
REGN |
Regeneron Pharmaceuticals... |
SVP Res and Dev Sciences |
|
2009-07-27 |
4 |
AS |
$20.74 |
$558,232 |
D/D |
(26,886) |
350 |
0 |
- |
|
REGN |
Regeneron Pharmaceuticals... |
SVP Res and Dev Sciences |
|
2010-12-14 |
4/A |
A |
$0.00 |
$0 |
D/D |
50,000 |
50,350 |
0 |
- |
|
REGN |
Regeneron Pharmaceuticals... |
SVP Res and Dev Sciences |
|
2011-03-30 |
4 |
OE |
$13.00 |
$99,996 |
D/D |
7,692 |
58,042 |
0 |
- |
|
REGN |
Regeneron Pharmaceuticals... |
SVP Res and Dev Sciences |
|
2011-03-30 |
4 |
AS |
$45.00 |
$346,140 |
D/D |
(7,692) |
50,350 |
0 |
- |
|
REGN |
Regeneron Pharmaceuticals... |
SVP Res and Dev Sciences |
|
2011-04-04 |
4 |
OE |
$13.00 |
$1,200,004 |
D/D |
92,308 |
142,658 |
0 |
- |
|
REGN |
Regeneron Pharmaceuticals... |
SVP Res and Dev Sciences |
|
2011-04-04 |
4 |
D |
$45.53 |
$2,649,527 |
D/D |
(58,193) |
84,465 |
0 |
- |
|
REGN |
Regeneron Pharmaceuticals... |
SVP Res and Dev Sciences |
|
2011-04-05 |
4 |
AS |
$45.83 |
$1,572,656 |
D/D |
(34,115) |
50,350 |
0 |
- |
|
REGN |
Regeneron Pharmaceuticals... |
SVP Res and Devel Sciences |
|
2012-11-20 |
4 |
OE |
$16.80 |
$915,600 |
D/D |
54,500 |
104,219 |
0 |
- |
|
REGN |
Regeneron Pharmaceuticals... |
SVP Res and Devel Sciences |
|
2012-11-20 |
4 |
D |
$167.17 |
$5,039,005 |
D/D |
(30,143) |
83,478 |
0 |
- |
|
REGN |
Regeneron Pharmaceuticals... |
SVP Res and Devel Sciences |
|
2012-11-21 |
4 |
S |
$173.80 |
$4,245,442 |
D/D |
(24,357) |
59,121 |
0 |
- |
|
REGN |
Regeneron Pharmaceuticals... |
SVP Res and Devel Sciences |
|
2012-11-30 |
4 |
S |
$181.01 |
$3,110,114 |
D/D |
(17,182) |
41,939 |
0 |
- |
|
REGN |
Regeneron Pharmaceuticals... |
SVP Res and Devel Sciences |
|
2012-11-30 |
4 |
OE |
$20.32 |
$199,994 |
D/D |
9,483 |
51,422 |
0 |
- |
|
REGN |
Regeneron Pharmaceuticals... |
SVP Res and Devel Sciences |
|
2012-12-14 |
4 |
D |
$179.13 |
$1,502,184 |
D/D |
(8,386) |
43,036 |
0 |
- |
|
REGN |
Regeneron Pharmaceuticals... |
SVP Res and Devel Sciences |
|
2012-12-17 |
4 |
OE |
$16.80 |
$99,994 |
D/D |
5,952 |
48,988 |
0 |
- |
|
REGN |
Regeneron Pharmaceuticals... |
SVP Research and Development S |
|
2011-09-06 |
4 |
D |
$65.76 |
$3,226,054 |
D/D |
(49,058) |
84,110 |
0 |
- |
|
REGN |
Regeneron Pharmaceuticals... |
SVP Research and Development S |
|
2011-09-06 |
4 |
OE |
$11.64 |
$964,002 |
D/D |
82,818 |
133,168 |
0 |
- |
|
REGN |
Regeneron Pharmaceuticals... |
SVP Research and Development S |
|
2011-09-07 |
4 |
AS |
$67.47 |
$2,354,375 |
D/D |
(33,760) |
50,350 |
0 |
- |
|
REGN |
Regeneron Pharmaceuticals... |
SVP Research and Development S |
|
2012-02-13 |
4 |
D |
$113.35 |
$4,019,844 |
D/D |
(35,464) |
90,323 |
0 |
- |
|
REGN |
Regeneron Pharmaceuticals... |
SVP Research and Development S |
|
2012-02-13 |
4 |
OE |
$8.50 |
$566,661 |
D/D |
66,666 |
92,177 |
0 |
- |
|
140 Records found
|
|
Page 4 of 6 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|